Human NLRP1: Patients, Mutations & Indications

Time: 11:30 am
day: Day 1 - Track A - Morning


  • Learn how germline GoF NLRP1, or LoF DPP9, mutations activate the inflammasome in humans
  • Understand the various DAMPs and PAMPs that can trigger human NLRP1
  • Examine to what extent NLRP1 is a validated drug target for orphan and/or common clinical indications